Company Filing History:
Years Active: 2008
Title: The Innovative Mind of Runan Mei in Pharmaceutical Development
Introduction
Runan Mei is a notable inventor based in Hangzhou, China, who has made significant contributions to the field of pharmaceuticals. With a focus on improving the treatment of depression, Mei holds a patent that highlights his innovative approach to the synthesis of citalopram, a widely used antidepressant.
Latest Patents
Mei's patent titled "Crystalline citalopram diol intermediate alkali" pertains to a diol intermediate of citalopram that is essential for the treatment of depression. This invention encompasses the crystal form of the free base of 3-hydroxylmethyl-4-[1-(4-fluorophenyl)-1-hydroxyl-4-(dimethylamino)]butylbenzonitrile, along with its crystallization method. His work provides a groundbreaking method for preparing pure citalopram and its purified salts through crystallization, offering improvements in product quality and yield while reducing production costs.
Career Highlights
Runan Mei is affiliated with Hangzhou Minsheng Pharmaceutical Co. Ltd, where he has demonstrated exceptional expertise in pharmaceutical innovation. His work continues to influence the production of high-quality medicinal materials, contributing to advancements in mental health treatment.
Collaborations
Throughout his career, Mei has collaborated with esteemed colleagues such as Dianwu Guo and Shulong Wang. Their collective efforts in research and development further enhance the potential impact of their innovations in the pharmaceutical industry.
Conclusion
In conclusion, Runan Mei stands out as an inventor whose contributions to the synthesis of citalopram significantly improve treatment methodologies for depression. His innovative patent not only exemplifies his dedication to the field but also illustrates the ongoing advancements being made in pharmaceutical sciences.